OnKure Therapeutics (OKUR) Other Non Operating Income (2020 - 2024)

OnKure Therapeutics (OKUR) has 5 years of Other Non Operating Income data on file, last reported at $972000.0 in Q3 2024.

• Quarterly Other Non Operating Income fell 42.55% year-over-year to $972000.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $4.6 million (down 11.84% YoY) and the FY2023 annual result came in at $5.7 million, up 199.26% from the prior year.
• Other Non Operating Income retreated to $972000.0 in Q3 2024, from $1.0 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $1.7 million in Q3 2023 to a low of -$21000.0 in Q1 2022.
• A 5-year average of $568842.1 and a median of $119000.0 in 2022 frame the typical range for Other Non Operating Income.
• The widest YoY moves for Other Non Operating Income: up 5558.82% in 2022, down 1150.0% in 2022.
• Tracing OKUR's Other Non Operating Income over 5 years: stood at -$2000.0 in 2020, then jumped by 950.0% to $17000.0 in 2021, then jumped by 5558.82% to $962000.0 in 2022, then jumped by 50.94% to $1.5 million in 2023, then sank by 33.06% to $972000.0 in 2024.
• The last three Other Non Operating Income figures came in at $972000.0 (Q3 2024), $1.0 million (Q2 2024), and $1.1 million (Q1 2024), per Business Quant data.